Modular Medical to Present at Webull Webinar on October 14
News related to:Modular Medical, Inc · 1 min read
SAN DIEGO, October 7, 2026 /CourierPR/ -- Modular Medical, Inc., a commercial-stage medical device company, will present at the Webull Emerging & Innovative Companies Webinar on October 14, 2026. The webinar, scheduled for Wednesday at 1:00 p.m. Eastern Time, will feature a presentation by the company’s Chief Executive Officer, Jeb Besser.
The Pivot™ tubeless patch pump, a key focus of the presentation, is a wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion. This system is intended to offer a practical and accessible pathway from multiple daily injections to insulin pump therapy for a broader population of people living with diabetes. The pump is designed to deliver both basal and bolus insulin over a three-day wear period, making it a user-friendly and flexible option for those requiring intensive insulin therapy.
Modular Medical, Inc. (NASDAQ: MODD) is focused on developing innovative insulin delivery technologies to simplify diabetes management and increase access to insulin pump therapy. The company’s Pivot™ tubeless patch pump represents a significant step in this direction, aiming to provide a more convenient and accessible solution for individuals managing their diabetes.
The webinar will provide an opportunity for attendees to learn more about the Pivot™ tubeless patch pump and its potential impact on the diabetes management landscape.
The presentation will cover the technical aspects of the Pivot™ tubeless patch pump, its benefits, and the company’s plans for its full commercial launch. Attendees will have the chance to gain insights into how this innovative technology could revolutionize the way people manage their diabetes.
Modular Medical’s CEO, Jeb Besser, will share the company’s vision and the progress made in bringing the Pivot™ tubeless patch pump to market. The webinar is expected to attract a diverse audience, including healthcare professionals, investors, and individuals interested in the latest advancements in medical technology.